Kazia Therapeutics Ltd ADR (USD)
KZIA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range4.18 | 4.34
52-Wk Range2.11 | 9.74
Last Close4.23
Mkt Cap (m)27.68
Dividend yield-
ISINUS48669G1058
Volume21,082
Exchange VenueNAS

Company Profile

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.

Key Information
Price/Earning-
Price/Book2.70
Price/Sales-
P/CF-
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-61.43
Debt/Equity0.00

Legal Documents

Prospectus
en 28/09/2015
Annual Report
en 30/06/2019

Financials

Income Statement
USD201320142015201620172018
Revenue (m)1
Operating Income (m)-2-6-8-13-10-12
Net Income (m)-1-7-7-12-11-6
Basic EPS-0.90-4.76-2.99-2.82-2.28-1.25
Avg. Diluted Shares Outstanding (m)122455
Balance Sheet
USD201320142015201620172018
Current Assets (m)334534199
Non Current Assets (m)32111619
Total Assets (m)6546363628
Current Liabilities (m)232154
Total Liabilities (m)------
Total Equity (m)4245342519
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-9-6-6-12-11-9
Capital Expenditure (m)-1-
Figures are quoted in USD unless stated otherwise
-0.02 (-0.37%)
$
4.21
Last Price